Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
8.20
-0.13 (-1.56%)
At close: Nov 13, 2025, 4:00 PM EST
8.27
+0.07 (0.85%)
After-hours: Nov 13, 2025, 7:56 PM EST
Greenwich LifeSciences Market Cap
Greenwich LifeSciences has a market cap or net worth of $111.77 million as of November 13, 2025. Its market cap has decreased by -38.96% in one year.
Market Cap
111.77M
Enterprise Value
108.64M
1-Year Change
-38.96%
Ranking
Category
Stock Price
$8.20
Market Cap Chart
Since the IPO on September 25, 2020, Greenwich LifeSciences's market cap has increased from $68.69M to $111.77M, an increase of 62.72%. That is a compound annual growth rate of 9.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2025 | 113.47M | -23.13% |
| Dec 31, 2024 | 147.61M | 9.21% |
| Dec 29, 2023 | 135.16M | -30.79% |
| Dec 30, 2022 | 195.29M | -38.84% |
| Dec 31, 2021 | 319.29M | -31.08% |
| Dec 31, 2020 | 463.30M | 574.50% |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 911.30B |
| Johnson & Johnson | 468.34B |
| AbbVie | 412.21B |
| UnitedHealth Group | 307.13B |
| AstraZeneca | 275.24B |
| Novartis AG | 251.93B |
| Merck & Co. | 226.98B |
| Abbott Laboratories | 224.00B |